Related references
Note: Only part of the references are listed.Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients
Nihil Chitalia et al.
ATHEROSCLEROSIS (2012)
Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy
Sona Mitra et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Antioxidant Vitamins and Cardiovascular Disease
Jorge M. Nunez-Cordoba et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Mohamad Navab et al.
NATURE REVIEWS CARDIOLOGY (2011)
Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent
Bin Bao et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Effects of hemodialysis period on levels of blood trace elements and oxidative stress
Tulay Koca et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2010)
Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function
LaPrincess C. Brewer et al.
CURRENT DRUG TARGETS (2010)
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Anatol Kontush et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis
Illiana Meurs et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
The vitamin D system: a crosstalk between the heart and kidney
Mario Cozzolino et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Estimation of intake of zinc, copper and iron in the diet of patients with chronic renal failure treated by haemodialysis
Agnieszka Szpanowska-Wohn et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2008)
Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients
Saeed Abdelwhab Saeed et al.
HEMODIALYSIS INTERNATIONAL (2008)
Serum paraoxonase activity, high-sensitivity C-reactive protein, and lipoprotein disturbances in end-stage renal disease patients on long-term hemodialysis
Hanaa Lahrach et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Atherosclerosis in Hemodialysis Patientsthe Role of Microinflammation
Sebastjan Bevc et al.
RENAL FAILURE (2008)
Zinc deficiency and clinical practice - Validity of zinc preparations
Hiroyuki Yanagisawa
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2008)
Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet
Andrew Jenner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Longitudinal study of serum zinc and copper levels in Hemodialysis patients and their relation to biochemical markers
M. Navarro-Alarcon et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2006)
Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment
Jacek Rysz et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
Plasma lipoprotein abnormalities in hemodialysis patients - Clinical implications and therapeutic guidelines
Tetsuo Shoji et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2006)
Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: Selective secretion of PON1 and PON2
R Shamir et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Paraoxonase 1 (PON1) is present in postprandial chylomicrons
B Fuhrman et al.
ATHEROSCLEROSIS (2005)
Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells
S Deakin et al.
ATHEROSCLEROSIS (2005)
Lipid peroxidation and antioxidant enzymes in children with chronic renal failure
D Zwolinska et al.
PEDIATRIC NEPHROLOGY (2004)
Role of oxidative modifications in atherosclerosis
R Stocker et al.
PHYSIOLOGICAL REVIEWS (2004)
Effects of lipid abnormalities on arteriosclerosis and hemostatic markers in patients under hemodialysis
F Kushiya et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2003)
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
O Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease
ML Wratten et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
Paraoxonase and atherosclerosis
PN Durrington et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins
PM Abuja et al.
CLINICA CHIMICA ACTA (2001)
Role of oxidized low-density lipoprotein in the atherosclerosis of uremia
TB Drüeke et al.
KIDNEY INTERNATIONAL (2001)
Oxidant stress in hemodialysis: Prevention and treatment strategies
ML Wratten et al.
KIDNEY INTERNATIONAL (2000)
Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis
M Tepel et al.
KIDNEY INTERNATIONAL (2000)
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
M Aviram et al.
CIRCULATION (2000)
Share Paper
